Two years of talks aimed at striking a landmark global agreement on handling future pandemics failed to seal a deal in time on Thursday, and will restart next month for one final push.
Mar 29, 2024
0
7
Two years of talks aimed at striking a landmark global agreement on how to handle the next pandemics were headed for overtime Thursday, with a breakthrough still elusive.
Mar 28, 2024
0
1
Pfizer, BioNTech and Moderna are making combined profits of $65,000 every minute from their highly successful COVID-19 vaccines while the world's poorest countries remain largely unvaccinated, according to a new analysis.
Nov 16, 2021
2
6183
Russia's sovereign fund on Tuesday announced a deal with a top Indian vaccine manufacturer to produce the Russia-designed Sputnik V vaccine.
Jul 13, 2021
0
1
We will never end the death and destruction of COVID-19 until we get real about vaccine equity. In a month of high-level meetings from the G7 to the World Health Assembly, we have seen a lot of rhetoric from the global north, ...
Jun 21, 2021
0
1
The International Federation of Pharmaceutical Manufacturers and Associations expressed disappointment Wednesday at the United States' decision to support a global waiver on patent protections for Covid-19 vaccines.
May 6, 2021
0
4
Dr. Horea Rus is an expert in diagnosing and treating patients with multiple sclerosis, and his research laboratory at the University of Maryland is producing new tools for treating the disease that attacks the central nervous ...
May 8, 2019
0
2
Large for gestational age babies and congenital heart defects (CHD) are just two of several risks needing further examination in the emerging field of assisted reproductive technology, according to the editors of a special ...
May 1, 2018
1
3
"VONVENDI [von Willebrand factor (Recombinant)]", the new drug from Baxalta Incorporated, a global biopharmaceutical company recently spun off from Baxter International, has just been approved by the United States Food and ...
Dec 21, 2015
0
0
Shares of Protalix BioTherapeutics Inc. jumped in premarket trading Wednesday after the drug developer announced a deal that requires the Brazilian government to buy at least $280 million of the company's Gaucher disease ...
Jun 19, 2013
0
0
